Cargando…

Different composition of intraocular immune mediators in Posner-Schlossman-Syndrome and Fuchs’ Uveitis

Posner-Schlossman-Syndrome (PSS) is clinically characterized by acute, recurrent, mild, unilateral uveitis anterior accompanied by elevated intraocular pressure (IOP). Fuchs´ Uveitis (FU) is a chronic, low-grade-inflammatory disorder, involving anterior uvea and vitreous. The clinical findings show...

Descripción completa

Detalles Bibliográficos
Autores principales: Pohlmann, Dominika, Schlickeiser, Stephan, Metzner, Sylvia, Lenglinger, Matthias, Winterhalter, Sibylle, Pleyer, Uwe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6019249/
https://www.ncbi.nlm.nih.gov/pubmed/29944680
http://dx.doi.org/10.1371/journal.pone.0199301
_version_ 1783335087309324288
author Pohlmann, Dominika
Schlickeiser, Stephan
Metzner, Sylvia
Lenglinger, Matthias
Winterhalter, Sibylle
Pleyer, Uwe
author_facet Pohlmann, Dominika
Schlickeiser, Stephan
Metzner, Sylvia
Lenglinger, Matthias
Winterhalter, Sibylle
Pleyer, Uwe
author_sort Pohlmann, Dominika
collection PubMed
description Posner-Schlossman-Syndrome (PSS) is clinically characterized by acute, recurrent, mild, unilateral uveitis anterior accompanied by elevated intraocular pressure (IOP). Fuchs´ Uveitis (FU) is a chronic, low-grade-inflammatory disorder, involving anterior uvea and vitreous. The clinical findings show remarkable similarities as well as differences. In our study, we determine the composition of immune mediators in aqueous humor of patients with PSS and FU and evaluate if immune mediators play a crucial role in specific viral intraocular inflammation and IOP rises. Aqueous humor samples from 81 uveitis patients (= eyes) presenting with either PSS or FU were collected at one time point. Local intraocular antibody synthesis to rubella virus was confirmed in 65 patients, whereas 16 were tested positively for human cytomegalovirus. Thirteen patients with PSS and 10 patients with FU were treated with glaucoma medications. Additionally, 11 cataract patients acted as control group. Immune mediator concentrations were measured by Bio-Plex Pro assay. We observed in both PSS (IFN-γ: 174.9 pg/mL; TNF-α: 25.1 pg/mL) and FU (IFN-γ: 25.4 pg/mL; TNF-α: 27.2 pg/mL) groups a significantly increased level of T-helper 1 immune mediators compared to controls (IFN-γ, TNF-α: 0 pg/mL) [median]. Notably, PSS patients (IL-1RA: 73.4 pg/mL; IL-8: 199.4 pg/mL; IL-10: 33.4 pg/mL; IP-10: 126350 pg/mL) showed a stronger and more active ocular inflammatory response, than FU patients (IL-1RA: 4.3 pg/mL; IL-8: 72.4 pg/mL; IL-10: 1.6 pg/mL; IP-10: 57400 pg/mL). Furthermore, a negative correlation between mediators and IOP was seen in the PSS group, potentially caused by acetazolamide-treatment. Our findings show that immune mediators play a crucial role in specific viral intraocular inflammation and influence IOP levels. Remarkable similarities but also significant differences of immune mediator concentrations are apparent in PSS compared to FU. High concentrations of IL-1RA, IL-8, IL-10, and IP-10 correlate with active inflammation in PSS, while FU may trigger chronic inflammation. Our data also substantiated a very similar composition of cytokines in those patients from the PSS group suffering from ocular hypertension and thus offers a potential explanation model for a negative correlation between mediators and IOP.
format Online
Article
Text
id pubmed-6019249
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-60192492018-07-07 Different composition of intraocular immune mediators in Posner-Schlossman-Syndrome and Fuchs’ Uveitis Pohlmann, Dominika Schlickeiser, Stephan Metzner, Sylvia Lenglinger, Matthias Winterhalter, Sibylle Pleyer, Uwe PLoS One Research Article Posner-Schlossman-Syndrome (PSS) is clinically characterized by acute, recurrent, mild, unilateral uveitis anterior accompanied by elevated intraocular pressure (IOP). Fuchs´ Uveitis (FU) is a chronic, low-grade-inflammatory disorder, involving anterior uvea and vitreous. The clinical findings show remarkable similarities as well as differences. In our study, we determine the composition of immune mediators in aqueous humor of patients with PSS and FU and evaluate if immune mediators play a crucial role in specific viral intraocular inflammation and IOP rises. Aqueous humor samples from 81 uveitis patients (= eyes) presenting with either PSS or FU were collected at one time point. Local intraocular antibody synthesis to rubella virus was confirmed in 65 patients, whereas 16 were tested positively for human cytomegalovirus. Thirteen patients with PSS and 10 patients with FU were treated with glaucoma medications. Additionally, 11 cataract patients acted as control group. Immune mediator concentrations were measured by Bio-Plex Pro assay. We observed in both PSS (IFN-γ: 174.9 pg/mL; TNF-α: 25.1 pg/mL) and FU (IFN-γ: 25.4 pg/mL; TNF-α: 27.2 pg/mL) groups a significantly increased level of T-helper 1 immune mediators compared to controls (IFN-γ, TNF-α: 0 pg/mL) [median]. Notably, PSS patients (IL-1RA: 73.4 pg/mL; IL-8: 199.4 pg/mL; IL-10: 33.4 pg/mL; IP-10: 126350 pg/mL) showed a stronger and more active ocular inflammatory response, than FU patients (IL-1RA: 4.3 pg/mL; IL-8: 72.4 pg/mL; IL-10: 1.6 pg/mL; IP-10: 57400 pg/mL). Furthermore, a negative correlation between mediators and IOP was seen in the PSS group, potentially caused by acetazolamide-treatment. Our findings show that immune mediators play a crucial role in specific viral intraocular inflammation and influence IOP levels. Remarkable similarities but also significant differences of immune mediator concentrations are apparent in PSS compared to FU. High concentrations of IL-1RA, IL-8, IL-10, and IP-10 correlate with active inflammation in PSS, while FU may trigger chronic inflammation. Our data also substantiated a very similar composition of cytokines in those patients from the PSS group suffering from ocular hypertension and thus offers a potential explanation model for a negative correlation between mediators and IOP. Public Library of Science 2018-06-26 /pmc/articles/PMC6019249/ /pubmed/29944680 http://dx.doi.org/10.1371/journal.pone.0199301 Text en © 2018 Pohlmann et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Pohlmann, Dominika
Schlickeiser, Stephan
Metzner, Sylvia
Lenglinger, Matthias
Winterhalter, Sibylle
Pleyer, Uwe
Different composition of intraocular immune mediators in Posner-Schlossman-Syndrome and Fuchs’ Uveitis
title Different composition of intraocular immune mediators in Posner-Schlossman-Syndrome and Fuchs’ Uveitis
title_full Different composition of intraocular immune mediators in Posner-Schlossman-Syndrome and Fuchs’ Uveitis
title_fullStr Different composition of intraocular immune mediators in Posner-Schlossman-Syndrome and Fuchs’ Uveitis
title_full_unstemmed Different composition of intraocular immune mediators in Posner-Schlossman-Syndrome and Fuchs’ Uveitis
title_short Different composition of intraocular immune mediators in Posner-Schlossman-Syndrome and Fuchs’ Uveitis
title_sort different composition of intraocular immune mediators in posner-schlossman-syndrome and fuchs’ uveitis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6019249/
https://www.ncbi.nlm.nih.gov/pubmed/29944680
http://dx.doi.org/10.1371/journal.pone.0199301
work_keys_str_mv AT pohlmanndominika differentcompositionofintraocularimmunemediatorsinposnerschlossmansyndromeandfuchsuveitis
AT schlickeiserstephan differentcompositionofintraocularimmunemediatorsinposnerschlossmansyndromeandfuchsuveitis
AT metznersylvia differentcompositionofintraocularimmunemediatorsinposnerschlossmansyndromeandfuchsuveitis
AT lenglingermatthias differentcompositionofintraocularimmunemediatorsinposnerschlossmansyndromeandfuchsuveitis
AT winterhaltersibylle differentcompositionofintraocularimmunemediatorsinposnerschlossmansyndromeandfuchsuveitis
AT pleyeruwe differentcompositionofintraocularimmunemediatorsinposnerschlossmansyndromeandfuchsuveitis